The FDA ordered that the class of drugs known as TNF blockers carry a warning on the packaging that their use carries the risk of developing a potentially deadly fungal disease called histoplasmosis. [...]
|
|||||||
 |
Anti-tumor necrosis factor (TNF) drugs are the newest class of therapies used for treating inflammatory diseases, such as Crohn’s disease, psoriasis and rheumatoid arthritis (RA). Our last post discussed the benefits of treating RA with a combination of anti-TNF medication and methotrexate. But there is new research that indicates concern for treating certain individuals with [...] Biogen Idec Inc. announced on October 9th that it was discontinuing development of its investigational rheumatoid arthritis (RA) drug baminercept after if failed to meet Phase II study [...] Earlier this year British researchers raised a concern that anti-TNF drugs, as a result of their action in depressing the immune system, may increase the overall risk of cancer. Spanish researchers who are presenting their research at the American College of Rheumatology’s annual meeting in San Francisco say their studies do not support that [...] Rheumatoid arthritis (RA) patients have been treated with several different drugs, including Enbrel (etanercept) and methotrexate. Now a study conducted in the United Kingdom indicates that treatment with a combination of Enbrel (an anti-TNF), and methotrexate increases the remission rate. Nearly 550 RA patients from Europe, Asia, Australia and Latin America, none of whom had used [...] |
  
|
|||||
|
Copyright © 2010 Current Arthritis News and Research - All Rights Reserved
|
|||||||
Recent Comments